1. Di Lorenzo C, Lucanto C, Flores AF, Idries S, Hyman PE. Effect of octreotide on gastrointestinal motility in children with functional gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 1998;27(5):508–12 (Epub 1998/11/20).
2. Lecomte T, Cavicchi M, Delchier JC. Small bowel pseudo-obstruction revealing an early scleroderma. Long-term efficacy of octreotide and erythromycin. Gastroenterol Clin Biol. 2000;24(3):361–3 (pii: MDOI-GCB-03-2000-24-3-0399-8320-101019-ART16. Epub 2000/05/11).
3. Leonardi G, de Bortoli N, Bellini M, Mumolo MG, Costa F, Ricchiuti A, et al. Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding. World J Gastrointest Pharmacol Ther. 2010;1(6):135–6. doi:
10.4292/wjgpt.v1.i6.135
(Epub 2011/05/18).
4. Ishikawa M, Okada J, Kondo H. Five cases of systemic sclerosis with associated with intestinal pseudo-obstruction. Ryumachi. 1999;39(5):768–73 (Epub 1999/12/30).
5. Lanting PJ, Kruijsen MW, Rasher JJ, van den Hoogen FH, Boerbooms AM, van de Putte LB. Severe intestinal pseudoobstruction in a patient with systemic sclerosis. Successful treatment with octreotide. J Rheumatol. 1993;20(12):2175 (Epub 1993/12/01).